CLINICAL TRIAL INFORMATION AND RECRUITMENT
TG Therapeutics is committed to the development of innovative medicines and unique combinations that deliver novel treatments for patients suffering from B-cell malignancies and autoimmune diseases. An integral part of achieving this goal is the conduct of robust and efficient clinical trials at the highest standards of quality attainable.
Information on all of TG Therapeutics’ ongoing clinical trials, including information for healthcare providers and patients interested in participating in any ongoing clinical trials, can be found at www.ClinicalTrials.gov,
Our REGISTRATION-DIRECTED AND PIVOTAL PHASE 3 TRIALS
PHASE 2b UNITY-NHL TRIAL
ONGOING, BUT NO LONGER RECRUITING
PHASE 2 ULTRA-V TRIAL
ONGOING, BUT NO LONGER RECRUITING
PHASE 3 ULTIMATE I & II TRIALS
ONGOING, BUT NO LONGER RECRUITING
UNITY-CLL PHASE 3 TRIAL
ONGOING, BUT NO LONGER RECRUITING